Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice

References

• WolffRClarCLerchCKleijnenJEpidemiologie von nicht tumorbedingten chronischen Schmerzen in Deutschland [Epidemiology of chronic non-malignant pain in Germany]Schmerz201125264421336883
   PubMed Web of Science ®Google Scholar
• Müller-SchwefeGHHEuropean survey of chronic pain patients: results for GermanyCurr Med Res Opin2011272099210621933101
   PubMed Web of Science ®Google Scholar
• VosTFlaxmanADNaghaviMYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet20123802163219623245607
   PubMed Web of Science ®Google Scholar
• FreynhagenRBaronRThe evaluation of neuropathic components in low back painCurr Pain Headache Rep20091318519019457278
   PubMed Web of Science ®Google Scholar
• MorlionBChronic low back pain: pharmacological, interventional and surgical strategiesNat Rev Neurol2013946247323817349
   PubMed Web of Science ®Google Scholar
• WenigCMSchmidtCOKohlmannTSchweikertBCosts of back pain in GermanyEur J Pain20091328028618524652
   PubMed Web of Science ®Google Scholar
• DeyoRAWeinsteinJNLow back painN Engl J Med200134436337011172169
   PubMed Web of Science ®Google Scholar
• MorlionBPharmacotherapy of low back pain: targeting nociceptive and neuropathic pain componentsCurr Med Res Opin201127113321083513
   PubMed Web of Science ®Google Scholar
• German Pain AssociationDGS-Praxisleitlinie Kreuzschmerz [Practice guideline low back pain] Available from: http://www.dgs-praxisleitlinien.de/Accessed December 14, 2014
   Google Scholar
• HäuserWBockFEngeserPTölleTWillweber-StrumpfAPetzkeFClinical practice guideline: long-term opioid use in non-cancer pain English version available from: http://www.awmf.org/leitlinien/detail/ll/145-003.htmlAccessed January 25, 2015
   Google Scholar
• LaucheRKlosePRadbruchLWelschPHäuserWOpioide bei chronischen nicht-tumorbedingten Schmerzen – gibt es Unterschiede? Systematische Übersicht und Metaanalyse der Wirksamkeit, Verträglichkeit und Sicherheit in randomisierten Direktvergleichen von Opioiden über mindestens 4 Wochen. [Opioids in chronic noncancer pain–are opioids different? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids of at least four week’s duration]Schmerz2015297384 English version available under dx.doi.org/10.1007/s00482-014-1432-4, supplementary material25376545
   PubMed Web of Science ®Google Scholar
• Mueller-LissnerSFixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipationAdv Ther20102758159020714946
   PubMed Web of Science ®Google Scholar
• CamilleriMOpioid-induced constipation: challenges and therapeutic opportunitiesAm J Gastroenterol201110683584221343919
   PubMed Web of Science ®Google Scholar
• ClemensKEMikusGCombined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic painExpert Opin Pharmacother20101129731020030568
   PubMed Web of Science ®Google Scholar
• BlagdenMHaferJDuerrHLong-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two phase III trialsNeurogastroenterol Motil2014261792180125346155
   PubMed Web of Science ®Google Scholar
• AhmedzaiSHLeppertWJaneckiMLong-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer painSupport Care Cancer20152382383025218610
   PubMed Web of Science ®Google Scholar
• UeberallMAMueller-SchwefeGHHSafety and efficacy of oxycodone/naloxone vs oxycodone vs morphine in the treatment of chronic low back pain: results of a 12-week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparationsCurr Med Res Opin2015311413142925942606
   PubMed Web of Science ®Google Scholar
• UeberallMAMueller-SchwefeGHHDevelopment of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioidsJ Pain Res2015845947526300655
   PubMed Web of Science ®Google Scholar
• The EuroQol GroupEuroQol – a new facility for the measurement of health-related quality of lifeHealth Policy19901619920810109801
   PubMed Web of Science ®Google Scholar
• GuyWECDEU Assessment Manual for PsychopharmacologyRockville, MDUS Department of Health, Education, and Welfare1976
   Google Scholar
• German Pain AssociationDer Deutsche SchmerzfragebogenGerman Pain Questionnaire Available from: http://www.dgss.org/deutscher-schmerzfragebogen/Accessed November 22, 2014
   Google Scholar
• von KorffMOrmelJKeefeFJDworkinSFGrading the severity of chronic painPain1992501331491408309
   PubMed Web of Science ®Google Scholar
• WareJJrKosinskiMKellerSDA 12-item short-form health survey: construction of scales and preliminary tests of reliability and validityMed Care1996342202338628042
   PubMed Web of Science ®Google Scholar
• GandekBWareJEAaronsonNKCross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA projectJ Clin Epidemiol199851117111789817135
   PubMed Web of Science ®Google Scholar
• FreynhagenRBaronRGockelUTölleTRpainDETECT: a new screening questionnaire to identify neuropathic components in patients with back painCurr Med Res Opin2006221911192017022849
   PubMed Web of Science ®Google Scholar
• SchmittNGerbershagenHUThe Mainz Staging System (MPSS) for chronic painPain199041Suppl 5S484 abstract
   Google Scholar
• RentzAMYuRMüller-LissnerSLeyendeckerPValidation of the bowel function index to detect clinically meaningful changes in opioid-induced constipationJ Med Econ20091237138319912069
   PubMedGoogle Scholar
• UeberallMAMüller-LissnerSBuschmann-KrammCBosseBThe bowel function index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patientsJ Int Med Res201139415021672306
   PubMed Web of Science ®Google Scholar
• ParkerSLAdogwaOMendenhallSKDetermination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosisSpine J2012121122112823158968
   PubMed Web of Science ®Google Scholar
• LangleyPCThe societal burden of pain in Germany: health-related quality-of-life, health status and direct medical costsJ Med Econ201215115
   Google Scholar
• BenyaminRTrescotAMDattaSOpioid complications and side effectsPain Physician200811S105S12018443635
   PubMed Web of Science ®Google Scholar
• ChaparroLEFurlanADDeshpandeAMailis-GagnonAAtlasSTurkDCOpioids compared to placebo or other treatments for chronic low-back painCochrane Database Syst Rev20138CD00495923983011
   PubMed Web of Science ®Google Scholar
• PetzkeFWelschPKlosePSchaefertRSommerCHäuserWOpioide bei chronischem Kreuzschmerz - Systematische Übersicht und Metaanalyse der Wirksamkeit, Verträglichkeit und Sicherheit in randomisierten, placebokontrollierten Studien über mindestens 4 Wochen [Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration]Schmerz2015296072 English version available under dx.doi.org/10.1007/s00482-014-1449-8, supplementary material25503883
   PubMed Web of Science ®Google Scholar
• KosinskiMRScheinJRVallowSMAn observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermalCurr Med Res Opin20052184986215969885
   PubMed Web of Science ®Google Scholar
• AllanLRicharzUSimpsonKSlappendelRTransdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back painSpine2005302484249016284584
   PubMed Web of Science ®Google Scholar
• WallaceMThipphawongJOpen-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back painPain Med2010111477148821199302
   PubMed Web of Science ®Google Scholar
• RychlikRViehmannKDanielDKienckePKresimonJPain management and costs of a combination of oxycodone + naloxone in low back pain patientsRaezGBNoeCEPain Management–Current Issues and OpinionsRijekaInTech2012 Available from: http://www.intechopen.com/books/pain-management-current-issues-and-opinionsAccessed June 10, 2015
   Google Scholar
• StrickVManagement of severe chronic pain with tapentadol prolonged release – long-term data from pain specialistsCurr Med Res Opin2014302085209224983745
   PubMed Web of Science ®Google Scholar
• Penning-van BeestFJvan den HaakPKlokRMPrevooYFvan der PeetDLHeringsRMQuality of life in relation to constipation among opioid usersJ Med Econ20101312913520128662
   PubMedGoogle Scholar
• SchutterUGrunertSMeyerCSchmidtTNolteTInnovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practiceCurr Med Res Opin2010261377138720380506
   PubMed Web of Science ®Google Scholar
• MorlionBClemensKEDunlopWQuality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxoneClin Drug Investig201535111
   PubMed Web of Science ®Google Scholar
• van DongenVCVanelderenPJKoopmans-KleinGvan MegenYJVan ZundertJHuygenFJPatient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study]Int J Clin Pract2014681364137524853258
   PubMed Web of Science ®Google Scholar